Gestational Diabetes Mellitus and Macrosomia: A Literature Review

Gestational diabetes mellitus and macrosomia: a literature review.

BACKGROUND Fetal macrosomia, defined as a birth weight ≥ 4,000 g, may affect 12% of newborns of normal women and 15-45% of newborns of women with gestational diabetes mellitus (GDM). The increased risk of macrosomia in GDM is mainly due to the increased insulin resistance of the mother. In GDM, a higher amount of blood glucose passes through the placenta into the fetal circulation. As a result,...

Gestational Diabetes Mellitus Update and Review of Literature

Gestational diabetes mellitus has been associated with various maternal and perinatal adverse outcomes. Screening and subsequent treatment are associated with short term benefit. With the recent recommended diagnostic criteria by the International Association of Diabetes and Pregnancy Study Groups and increasing rate of obesity, the prevalence will continue to rise. It remains uncertain whether...

Gestational diabetes mellitus

Introduction: Gestational diabetes mellitus (GDM) is defined as any degree of glucose intolerance with onset or first recognition during pregnancy. The prevalence range from 1 to 14% of all pregnancies, depending on the population studied and the diagnostic tests employed. Risk assessment for GDM should be undertaken at the prenatal visit. Women with clinical characteristics of GDM should und...

Prevalence of Gestational diabetes mellitus in Iran: A Systematic Review and Meta-analysis

A MicroRNA Signature in Gestational Diabetes Mellitus Associated with Risk of Macrosomia.

BACKGROUND/AIMS MicroRNA (miRNA) is a small non-coding RNA molecule that functions in regulation of gene expression by targeting mRNA to affect its stability and/or translation. The aim of this study was to evaluate the miRNAs involvement in gestational diabetes mellitus (GDM), a well known risk factor for fetal overgrowth. METHODS Differential microRNA expression in placental tissues of norm...